Yeganeh Reuven
SEC Form 4 insider trading activity
Yeganeh Reuven has filed 3 SEC Form 4 filings (9 transaction rows) across 2 companies, including PHGE, NUKK, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Mar 18, 2026.
On the most recent filing, Yeganeh Reuven is listed as Director, 10% Owner at BiomX Inc. Inside the rolling window, Yeganeh Reuven reported no open-market purchases and 4 open-market sales totaling $8.3M in PHGE. The largest disclosed transaction in the window is a sale of 530,000 PHGE shares on Mar 17, 2026, worth $2.6M.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$8.3M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Yeganeh Reuven made?
Yeganeh Reuven has filed 3 SEC Form 4 filings (9 transaction rows) across 2 companies, including PHGE, NUKK since 2025.
Which companies does Yeganeh Reuven trade?
Yeganeh Reuven has filed SEC Form 4 disclosures for 2 companies, including PHGE, NUKK.
When was Yeganeh Reuven's most recent SEC Form 4 filing?
Yeganeh Reuven's most recent SEC Form 4 filing on Tracefour is dated Mar 18, 2026.
What is Yeganeh Reuven's total buy and sell value in the current window?
Inside the rolling retention window, Yeganeh Reuven bought $0 and sold $8.3M based on SEC Form 4 filings.
What was Yeganeh Reuven's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 530,000 PHGE shares on 2026-03-17, worth $2.6M, per SEC Form 4 filings.